Abstract:Background: Yindan Xinnaotong soft capsule (YDXNT) is a clinically effective herbal prescription used for the treatment of cardiovascular and cerebrovascular diseases. Since Chinese medicines (CMs) exert their effects via a "multiple-components and multiple-targets" mode, discovery of the active compounds with interactive effects may contribute to reveal their mechanisms of action. Purpose: This study aimed to establish an image-based fingerprint-efficacy screening strategy to identify active compounds with interaction effects from CM prescription, using YDXNT to inhibit microglia-mediated neuroinflammation as an instance. Methods: A multi-component random content-oriented chemical library of YDXNT was constructed by uniform design, and their chemical fingerprint was profiled by liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-mass spectrometry (GC-MS) methods. Then the neuroinflammation activities of chemical library members of YDXNT were determined by image-based dual phenotypic quantification. Subsequently, fingerprint-efficacy correlation and random forest analysis were applied to predict the potentially active compounds with interactive effects. Finally, the interactive effects among the active compounds were confirmed by quantitative polymerase chain reaction (qPCR) and apoptosis analysis, and network pharmacology was applied to explore the possible mechanisms. Results: Image-based fingerprint-efficacy correlation analysis revealed that six tanshinones (TNs) and four flavonoids (FAs) were potential anti-neuroinflammatory compounds. The inter-family of TNs and FAs possessed obvious interactive effects (combination index <= 0.825). Moreover, the combination of scutellarein and tanshinone I (2:1, w/w) was discovered as the possible interactive combinatorial components, which, comparing with individual scutellarein or tanshinone I, shown more powerful effects on anti-inflammatory and antiapoptotic effects in lipopolysaccharide (LPS)-induced BV2 cells. Network pharmacology showed that the active compounds might suppress microglia-mediated neuroinflammation via multiple targets in the T cell receptor, Jak-STAT, and Toll-like receptor signaling pathways. Conclusion: The image-based fingerprint-efficacy strategy simplifies the screening process of efficacious component combinations in CMs for complex diseases, which also offers a promising approach to explore the integrative therapeutic mechanisms of CMs.

Rapid Identification of Anti-Inflammatory Compounds from Tongmai Yangxin Pills by Liquid Chromatography with High-Resolution Mass Spectrometry and Chemometric Analysis

[Screening of Active Compounds with Myocardial Protective Effects from Tongmai Yangxin Pill].

Deciphering the Differentiations of Traditional Chinese Medicine Analogous Formulae by Parallel Liquid Chromatography-Mass Spectrometry Coupled with Microplate-Based Assays

Rapid discovery and identification of anti-inflammatory constituents from traditional Chinese medicine formula by activity index, LC-MS, and NMR

Rapid discovery and identification of the anti-inflammatory constituents in Zhi-Shi-Zhi-Zi-Chi-Tang

Identification of anti-inflammatory active ingredients from Tumuxiang by ultra-performance liquid chromatography/quadrupole time-of-flight-MS E .

Identification of the effective constituents for anti-inflammatory activity of Ju-Zhi-Jiang-Tang, an ancient traditional Chinese medicine formula

Dual-bioactivity-based liquid chromatography-coupled quadrupole time-of-flight mass spectrometry for NF-κB inhibitors and β 2 AR agonists identification in Chinese Medicinal Preparation Qingfei Xiaoyan Wan

Development of a HPLC-MS/MS Method to Determine 11 Bioactive Compounds in Tongmai Yangxin Pill and Application to a Pharmacokinetic Study in Rats

An Image-Based Fingerprint-Efficacy Screening Strategy for Uncovering Active Compounds with Interactive Effects in Yindan Xinnaotong Soft Capsule.

Bioactivity-integrated Ultra-Performance Liquid Chromatography/quadrupole Time-of-flight Mass Spectrometry for the Identification of Nuclear Factor-Κb Inhibitors and Β2 Adrenergic Receptor Agonists in Chinese Medicinal Preparation Chuanbeipipa Dropping Pills.

Identification of nuclear factor-κB inhibitors and β2 adrenergic receptor agonists in Chinese medicinal preparation Fuzilizhong pills using UPLC with quadrupole time-of-flight MS

Clinical metabolomics analysis of therapeutic mechanism of Tongmai Yangxin Pill on stable angina

Analysis of bioactive components and pharmacokinetic study of herb-herb interactions in the traditional Chinese patent medicine Tongmai Yangxin Pill.

A Pre-Classification Strategy for Identification of Compounds in Traditional Chinese Medicine Analogous Formulas by High-Performance Liquid Chromatography–mass Spectrometry

Rapid Determination of 30 Polyphenols in Tongmai Formula, a Combination of Puerariae Lobatae Radix, Salviae Miltiorrhizae Radix et Rhizoma, and Chuanxiong Rhizoma, via Liquid Chromatography-Tandem Mass Spectrometry

Rapid Discovery and Identification of 68 Compounds in the Active Fraction from Xiao-Xu-Ming Decoction（xxmd） by HPLC-HRMS and MTSF Technique

Identification Of Nuclear Factor-Kappa B Inhibitors And Beta(2) Adrenergic Receptor Agonists In Chinese Medicinal Preparation Fuzilizhong Pills Using Uplc With Quadrupole Time-Of-Flight Ms

Identification of Multiple Constituents in Chinese Medicinal Prescription Shensong Yangxin Capsule by Ultra-Fast Liquid Chromatography Combined with Quadrupole Time-Of-Flight Mass Spectrometry

Rapid Separation and Characterization of Comprehensive Ingredients in Yangxinshi Tablet and Rat Plasma by Ultrahigh-Performance Liquid Chromatography–quadrupole Time-of-flight Mass Spectrometry

Quality Evaluation of Traditional Chinese Medicine Compounds in Xiaoyan Lidan Tablets: Fingerprint and Quantitative Analysis Using UPLC-MS.